An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies
Semaglutide is administered subcutaneously once weekly and has a half-life of approximately one week, allowing steady-state concentrations to be maintained
For some patients this may not be practical, and currently there are no data regarding the efficacy of oral semaglutide with dosing conditions (e.g., different times or fasting periods) other than those used in the PIONEER trials
The earlier 12-week Phase 2a trial had shown encouraging results (2.6 kg vs 0.8 kg for placebo), but the larger, longer, better-powered trial reversed that finding
Ive spent 20 years trying to sell the benefits of a 5 percent weight loss, said Dr
While gallbladder-related issues are less common compared to other gastrointestinal side effects, they can cause significant discomfort for some patients, particularly during the dose-escalation phase and periods of rapid weight loss